The market was none too pleased about the pharmacy retail chain's progress last quarter.
News & Analysis: Rite Aid
The drugstore operator's 1-for-20 reverse split means that the stock is in compliance, but investors continue to bail on the poorly performing investment.
The pharmacy operator is fine with selling cigarettes -- just not the electronic kind.
The negative impact of the pharmacy retailer's disappointing Q4 update last week continued to weigh on the stock.
RAD earnings call for the period ending March 2, 2019.
The pharmacy retailer's net loss wasn't as bad as expected. But its sales came in well below estimates.
The long-struggling pharmacy chain's earnings show the company still has a tough road ahead of it.
The stock market didn't make major moves on Thursday morning.
Rite Aid's board clears the way for a 1-for-20 reverse stock split later this month. Booking Holdings, LabCorp, and Citi have gone on to move higher after going this route.
Investors approved a move that should keep it on the New York Stock Exchange, but shares have now lost more than 90% of their value over the last three years.